TW200722522A - New compound colletoic acid - Google Patents
New compound colletoic acidInfo
- Publication number
- TW200722522A TW200722522A TW095118707A TW95118707A TW200722522A TW 200722522 A TW200722522 A TW 200722522A TW 095118707 A TW095118707 A TW 095118707A TW 95118707 A TW95118707 A TW 95118707A TW 200722522 A TW200722522 A TW 200722522A
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- new compound
- colletoic
- acid
- novel
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- ZIOMQRRFPWLXDN-XFMPKHEZSA-N (1S,4S,5S,9S)-9-hydroxy-8-methyl-1-propan-2-ylspiro[4.5]dec-7-ene-4-carboxylic acid Chemical compound CC(C)[C@@H]1CC[C@H](C(O)=O)[C@@]11C[C@H](O)C(C)=CC1 ZIOMQRRFPWLXDN-XFMPKHEZSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 102000008645 11-beta-Hydroxysteroid Dehydrogenase Type 1 Human genes 0.000 abstract 1
- 108010088011 11-beta-Hydroxysteroid Dehydrogenase Type 1 Proteins 0.000 abstract 1
- 102000004277 11-beta-hydroxysteroid dehydrogenases Human genes 0.000 abstract 1
- 108090000874 11-beta-hydroxysteroid dehydrogenases Proteins 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000001145 Metabolic Syndrome Diseases 0.000 abstract 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/30—Unsaturated compounds
- C07C62/32—Unsaturated compounds containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/50—Spiro compounds
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005153348 | 2005-05-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200722522A true TW200722522A (en) | 2007-06-16 |
Family
ID=37452077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095118707A TW200722522A (en) | 2005-05-26 | 2006-05-26 | New compound colletoic acid |
Country Status (2)
| Country | Link |
|---|---|
| TW (1) | TW200722522A (zh) |
| WO (1) | WO2006126654A1 (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024257791A1 (ja) * | 2023-06-12 | 2024-12-19 | グリーンケミカルズ株式会社 | 芳香族化合物組成物およびポリマー |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60317631T2 (de) * | 2002-02-01 | 2008-09-25 | Merck & Co., Inc. | 11-beta-hydroxysteroid-dehydrogenase-1-hemmer zur behandlung von diabetes, adipositas und dyslipidämie |
| TWI400239B (zh) * | 2004-11-10 | 2013-07-01 | Incyte Corp | 內醯胺化合物及其作為醫藥品之用途 |
-
2006
- 2006-05-25 WO PCT/JP2006/310497 patent/WO2006126654A1/ja not_active Ceased
- 2006-05-26 TW TW095118707A patent/TW200722522A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006126654A1 (ja) | 2006-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200706021B (en) | 1-thio-D-glucitol derivatives | |
| TW200615266A (en) | Organic compounds | |
| WO2005116002A3 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| WO2008033460A3 (en) | Treating pain, diabetes, and lipid metabolism disorders | |
| IN2015DN01132A (zh) | ||
| SI1807072T1 (sl) | Derivati cikloalkil laktamov kot inhibitorji 11-beta-hidroksisteroid dehidrogenaze 1 | |
| TW200637828A (en) | Novel cis-imidazolines | |
| CA2474578A1 (en) | Novel pyridin- and pyrimidin-derivatives | |
| WO2005044192A3 (en) | Triazole compounds and uses related thereto | |
| GB0225475D0 (en) | Therapeutic agents | |
| IL171977A (en) | Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same | |
| SE0001899D0 (sv) | New compounds | |
| WO2005075425A3 (en) | Substituted bisarylurea derivatives as kinase inhibitors | |
| IL187005A0 (en) | Diacylglycerol acyltransferase inhibitors | |
| GEP20084466B (en) | Beta d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | |
| GEP20084468B (en) | Gamma-d crystalline form of ivabradin hydrochloride, process for its preparation and pharmaceutical compositions containing it | |
| WO2002092072A3 (en) | Drugs for the treatment of the alzheimer disease | |
| WO2005075471A3 (en) | Thiazol-compounds as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors | |
| NO20070974L (no) | Substituerte N-acyl-2-aminotiazoler | |
| WO2006041631A3 (en) | Novel cyclosporin alkynes and their utility as pharmaceutical agents | |
| TW200722522A (en) | New compound colletoic acid | |
| PL365258A1 (en) | Pharmaceutical composition comprising deramciclane for the treatment of the decline and/or damage of cognitive functions | |
| NO20063860L (no) | 7-fenylamino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav samt deres anvendelse som legemidler | |
| WO2003063858A3 (fr) | Derives de l'acide haloacetamidobenzoique et leur utilisation pour le traitement de maladies parasitaires | |
| TW200630097A (en) | Methods of using PDE V inhibitors for the treatment of congestive heart failure |